UMC has an international Board; WHO and the Swedish Government each appoints three members, and three alternate members.
The operations of the UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish Government. The Centre has an international Board; WHO and the Swedish Government each appoints three members, and three alternate members.
From May 2019 the Chairman of the Board is Dr Filippa Nyberg, Chief Medical Officer, Karolinska University Hospital, Associate Professor, Karolinska Institutet.
The other members appointed by the Swedish Government are:
Professor Johanna Adami, Principal, Sophiahemmet University
Dr Thomas Bradley, Clinical Pharmacologist, Karolinska University Hospital
Professor Gert Ragnarsson
Karin Meyer, Director, Apotekarsocieteten
WHO has appointed:
Ms Emer Cooke, Head, Regulation of Medicines and other Health Technologies, Essential Medicines and Health Products, World Health Organization
Dr Gayatri Jayaraman, Marketed Health Products Safety and Effectiveness Information Bureau, Canada
Dr Fred Moin Siyoi, CEO, Pharmacy and Poisons Board, Kenya
Dr Shanthi Pal, Group Lead, Medicines Safety, Safety & Vigilance, World Health Organization
Dr Jun Kitahara, Director, International Information Group, Risk Communication Promotion Division, Safety, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mr Mick Foy, Group Manager, MHRA , Vigilance and Risk Management of Medicines